BLFS - CIK 0000834365
BIOLIFE SOLUTIONS INC trades as BLFS and has a market capitalization of $1.30 B, making it the #2436 largest US-listed company by market value. In its fiscal 2025 annual report the company posted revenue of $96.21M, up 28.9% from the prior year and net income of -$4.59M. This page tracks BIOLIFE SOLUTIONS INC through 1,679 SEC filings, with financial statements and metrics updated as new reports are filed.
Over the last 11 fiscal years BIOLIFE SOLUTIONS INC's revenue grew from $6.19M to $96.21M, a compound annual growth rate of 28.3%. Net profit margin expanded from -22.8% to -4.8% over the same period - every figure below comes from the company's audited annual filings.
| Filing | Type | Filed |
|---|---|---|
| SCHEDULE 13D/A | - | 2026-05-22 |
| Insider trade | 4 | 2026-05-21 |
| Insider sale notice | 144 | 2026-05-21 |
| Insider sale notice | 144 | 2026-05-20 |
| Insider sale notice | 144 | 2026-05-19 |
| SCHEDULE 13G/A | - | 2026-05-15 |
| Quarterly report | 10-Q | 2026-05-07 |
| Major company event | 8-K | 2026-05-07 |
The largest companies sharing BIOLIFE SOLUTIONS INC's SEC industry classification (electromedical & electrotherapeutic apparatus).
BIOLIFE SOLUTIONS INC (BLFS) has a market capitalization of $1.30 B as of 2026-06-11, ranking #2436 among US-listed companies.
BIOLIFE SOLUTIONS INC reported revenue of $96.21M for fiscal year 2025, an increase of 28.9% year over year.
In its latest fiscal year BIOLIFE SOLUTIONS INC reported a net loss of $4.59M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.